Drawing for Serial No. 86524164

USPTO serial 86524164

Serial No. 86524164

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUCHANAN WILL, NORA
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 86524164?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dana B. Robinson

Dana B. Robinson TechLaw LLPPO Box 1416La Jolla, CA 92038UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents affecting metabolism; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of as well as management, diagnosis and prognosis of autoimmune, inflammatory, metastatic, hematologic, oncologic, neurologic and metabolic diseases, conditions, and disorders, and diseases, conditions, and disorders associated with misfolded proteins, and diseases, conditions and disorders affecting the systemic and central nervous system.; Pharmaceutical preparations for the treatment and prevention of as well as management, diagnosis and prognosis of the following specific list of enumerated indications: autoimmune, inflammatory, metastatic, hematologic, oncologic and neurologic diseases, conditions and disorders, and diseases, conditions and disorders associated with misfolded proteins, and diseases, conditions and disorders affecting the central nervous system, and psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host/graft rejections, Alzheimer's and Parkinson's-disease, insulin resistance, systemic metabolic disorders, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, dementia pugilistica /chronic traumatic encephalopathy, inclusion body myositosis, mild cognitive impairment, chronic inflammation, Familial Mediterranean Fever, plasma cell (B-cell) dyscrasias, prion diseases, dialysis related amyloidosis and carpal tunnel syndrome, senile cardiac amyloidosis, Familial Amyloidotic Polyneuropathy, medullary carcinoma of the thyroid and type II diabetesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 10, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 10, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 24, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 24, 2016NOACCORRECTED NOA E-MAILED—
Sep 23, 2016EX2GSOU EXTENSION 2 GRANTED—
Sep 23, 2016DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 8, 2016EXT2SOU EXTENSION 2 FILED—
Sep 8, 2016DRRRDIVISIONAL REQUEST RECEIVED—
Sep 8, 2016ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 8, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 27, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 3, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2016EX1GSOU EXTENSION 1 GRANTED—
May 27, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 19, 2016NREVNOTICE OF REVIVAL - E-MAILED—
Apr 19, 2016TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 19, 2016PETGPETITION TO REVIVE-GRANTED—
Apr 19, 2016PROATEAS PETITION TO REVIVE RECEIVED—
Apr 11, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 11, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 8, 2016EXT1SOU EXTENSION 1 FILED—
Sep 8, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 14, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 10, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2015ALIEASSIGNED TO LIE—
May 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 20, 2015XAECEXAMINER'S AMENDMENT ENTERED—
May 20, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 20, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
May 20, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
May 11, 2015DOCKASSIGNED TO EXAMINER—
Feb 14, 2015MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 13, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 7, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance